# iRegene raises RMB 210 million in Series C financing

On 2026-04-27, according to Xiniu Data, iRegene completed Series C financing, raising RMB 210 million. Investors were co-lead investor Nantongheyuanyihao Venture Capital Partnership (Limited Partnership), co-lead investor Xingze Capital. The company is a developer of chemically induced cell therapy drugs.



Canonical: https://uniquebase.ai/news/a3799465-6142-4482-a199-e95e03442e40
Stable identifier: a3799465-6142-4482-a199-e95e03442e40
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:21:37.692Z

## Connected profiles

- [Nantongheyuanyihao Venture Capital Partnership](/institutions/nantongheyuanyihao-venture-capital-partnership)
- [Xingze Capital](/institutions/xingze-capital)
- [iRegene](/companies/UB-C5987)

## Sources

- No source links are available for this profile.